Roche says Japan approves new formulation of arthritis drug (Yahoo)

ZURICH (Reuters) - Roche Holding AG's Japanese subsidiary Chugai said on Monday that Japanese health regulators have approved a new formulation of its rheumatoid arthritis drug Actemra. Japanese regulators have approved a subcutaneous formulation of Actemra which shortens the delivery time of the drug compared to an intravenous formulation and can be administered at home. Actemra was first launched with intravenous formulation in Japan for Castleman's disease and was later approved for rheumatoid arthritis. ...

Read the full article...

(From Yahoo Diseases)

Source: http://neurotalk.psychcentral.com/showthread.php?t=185901&goto=newpost

james harden breeders cup Mitch Lucker Red Cross CMA Awards 2012 election day Electoral College map